[ad_1] Samsung Bioepis headquarters in Songdo, Incheon [SAMSUNG BIOEPIS]  Samsung Bioepis signed an agreement with Switzerland’s Sandoz for the sales of its Stelara biosimilar drug in the North American…
[ad_1] Samsung Bioepis headquarters in Songdo, Incheon [SAMSUNG BIOEPIS]  Samsung Bioepis signed an agreement with Switzerland’s Sandoz for the sales of its Stelara biosimilar drug in the North American…